organized by

pain

ting

by

C. B

oko

ros

scientific program

masterclass of sarcomaand rare cancers

Congress & Event Planning2-4, Kastriotou Str., P.O. 11476, Athens - Greece Τ +30 210 7294559 E info@eventema.gr

with the Scientific Collaboration of Hellenic Group of Sarcoma and Rare Cancer

unter the auspices of

march 15-16 2019royal olympic hotelathens greece

2 3

ORGANIZING COMMITTEEI. Boukovinas

J. Duran-Moreno

S. Kokkali

V. Kontogeorgakos

SCIENTIFIC COMMITTEEG. Agrogiannis

I. Athanasiadis

I. Boukovinas

A. Constantinidou

E. de Bree

A. Digklia

J. Duran-Moreno

V. Georgoulias

S. Kokkali

V. Kontogeorgakos

N. Memos

D. Papachristou

I. Papanastasiou

V. Ramfidis

E. Skarpidi

A. Stergioula

Dear colleagues,

The Hellenic Group of Sarcoma and Rare Diseases (HG-SRC) and the Hellenic Oncology Re-

search Group (HORG) are pleased to welcome you in Athens, at the Royal Olympic Hotel, on

March 15th-16th 2019 for a Masterclass of Sarcoma and Rare Cancers. The event aims to induce

an interest in the challenging field of sarcomas amongst the local medical community, by com-

bining background knowledge and contemporary developments in the management of these

rare diseases. The Masterclass is addressed to pathologists, oncologists, radiation oncologists,

surgeons, orthopedics as well as any other scientific groups dealing with sarcomas.

The sessions held during the Masterclass will include an introduction to the characteristics of

different sarcoma subtypes and presentations on the diagnosis and management of a wide

range of sarcoma cases. Emphasis will be placed on presenting the latest diagnostic and thera-

peutic advances in each area. A prestigious faculty from all over Europe representing various

disciplines involved in the management of sarcoma subtypes will provide an excellent opportu-

nity for scientific and didactic sessions presented to Greek physicians.

After the success of the first official meeting of the Hellenic Group of Sarcoma on January

2018, and as a continuation of this initiative for the integrated treatment of sarcoma patients in

Greece, a second official meeting will take place during the meeting’s last session. The success

of this effort relies on comprehensive work, but also on everyone’s dedication and active sup-

port to this educational seminar.

Within the grounds of the Masterclass of sarcomas, we wish to welcome you and warmly thank

you for your participation.

The Organizing Committee

I. Boukovinas MD, PhD, PharmaD

Medical Oncologist, Head of Oncology Unit, Bioclinic Thessaloniki

J. Duran-Moreno MD, MSc

Medical Oncologist, 4th Department of Internal Medicine,University General Hospital “Attiko”, Athens

S. Kokkali MD, MSc

1st Department of Medical Oncology, “Saint Savvas” Anticancer Hospital, Athens

V. Kontogeorgakos

Assistant Professor of Orthopaedics Surgery, Medical School, University of Athens

4

FRIDAY 15/03/201911.00-11.30 R E G I S T R AT I O N . W E LC O M E V. Kontogeorgakos, J. Duran-Moreno

11.30-13.00 STS FREQUENT SUBTYPES Chairs: N. Memos, I. Papanastasiou

11.30-12.00 Circulating tumor cells and ctDNA in sarcoma E. Lianidou 12.00-12.30 Image-guided biopsy A. Karatzas 12.30-13.00 Molecular subtypes. New methods available E. Papadopoulou

13.00-14.30 LUNCH

14.30-16.00 GIST Chairs: I. Athanasiadis, V. Ramfidis

14.30-15.00 WT-GIST, perspectives for new subtypes? E. Skarpidi 15.00-15.30 The role of EUS in diagnosis of GIST and endoscopic resection D. Kypraios 15.30-16.00 Neoadjuvant treatment in locally advanced M. Cordeiro

16.00-16.30 LECTURE Chairs: J. Duran-Moreno, I. Karavokyros

16.00-16.30 Surgical treatment of RPS N. Memos

16.30-17.00 C O F F E E B R E A K

17.00-19.00 BONE TUMORS Chairs: D. Kelekis, I. Kotsantis

17.00-17.30 Response to neoadjuvant. What is so difficult? K. Diamantopoulou 17.30-18.00 GCT with Denosumab. Neoadjuvant or definite treatment? J. Duran-Moreno 18.00-18.30 Primary Bone Sarcoma. Surgical Treatments V. Kontogeorgakos 18.30-19.00 Salvage therapies V. Ramfidis

19.00 C LO S I N G R E M A R K S

7

SATURDAY 16/03/201909.00-11.30 STS FREQUENT SUBTYPES II Chairs: S. Kokkali, A. Stergioula

09.00-09.30 Liposarcoma subtypes and differences in approach G. Agrogiannis 09.30-10.00 Surgical treatment of STS of the extremities N. A. Stavropoulos 10.00-10.30 Emerging therapies in STS (MDM2, EZH2, immuno) S. Stacchiotti 10.30-11.00 NBTXR3 + RT for locally advanced sarcoma S. Bonvalot 11.00-11.30 What patient benefits from adjuvant chemotherapy? A. Sebio Garcia

11.30-12.00 C O F F E E B R E A K

12.00-14.00 RARE SARCOMAS / PAEDIATRIC SARCOMA

Chairs: D. Raptis, V. Georgoulias

12.00-12.30 The most difficcult diagnosis D. Papachristou 12.30-13.00 Imaging of pediatric bone sarcomas M. Vlychou 13.00-13.30 Management of pediatric sarcomas H. Vasilatou - Kosmidis 13.30-14.00 Targeting new targets in rare sarcomas S. Kokkali

14.00-14.30 BREAST SARCOMA A. Digklia

14.30-15.30 L U N C H

15.30-17.00 GYNECOLOGICAL SARCOMA Chairs: D. Bafaloukos, E. de Bree

15.30-16.00 Morcellation. How to avoid it? V. Sioulas 16.00-16.30 The role of radiotherapy in gynecological sarcoma L. Vini 16.30-17.00 Metastatic endometrial sarcoma. A review of literature A. Kyriazoglou

17.00-18.30 POLICY OF SARCOMA MANAGEMENT Chairs: I. Boukovinas, A. Constantinidou

17.00-17.30 Multidisciplinar tumor board M. Montemurro 17.30-18.00 Access to new agents and off-label indications D. Tzaninis 18.00-18.30 The challenges of Sarcoma patients and how patient advocates & experts together can achieve changes. M. Wartenberg

9

18.30-20.00 DISCUSSION OF CLINICAL CASES Chairs: V. Kontogeorgakos, J. Duran-Moreno

18.30-18.45 Case 1 A. Constantinidou 18.45-19.00 Case 2 N. Memos 19.00-19.15 Case 3 E.S. Tripodaki, E. Magkou 19.15-19.30 Case 4 D. Diakoumis 19.30-19.45 Case 5 L. Vini 19.45-20.00 Case 6 G. Agrogiannis

20.00-20.30 FINAL REMARKS Chairs: V. Kontogeorgakos, J. Duran-Moreno

Hellenic Group of Sarcoma and Rare Cancer (HG-SRC). Update 2018-2019. (For Greek professionals only)

11

E. Magkou Resident of Clinical Oncology, 1st Department of Clinical Oncology, Saint Savvas Anti-cancer Hospital, Athens Greece

N. Memos MD, PhD, MSc, Surgical Oncologist Sarcoma, Melanoma, and Rare Tumors, A’ Depart-ment Of Propaedeutic Surgery, Athens Medical School, Athens, Greece

M. Montemurro Consultant Medical Oncologist, Medical Oncology, CHUV University Hospital Lausanne, Switzerland

D. Papachristou MD, PhD, Consultant Histopathologist, Professor at University of Patras, School of Medicine, Scientific Coordinator, Unit of Bone and Soft Tissue Studies, Department of Anatomy-His-tology-Embryology, Adj. Professor, Department. of Pathology, Uniersity. of Pittsburgh, Pittsburgh, PA, USA, Scientific Coordinator, Department of Pathology Olympion General Clinic, Patras, Greece

E. Papadopoulou PhD, Group Leader of Molecular Oncology, Genekor Medical S.A., Athens, Greece

I. Papanastasiou MD, PhD, General Oncological Hospital Kifisias Agioi Anargyroi, Athens, Greece

V. Ramfidis MD, MSc, Medical Oncologist, 251 General Air Force Hospital, Sotiria General Hospi-tal University of Athens, Athens, Greece

D. Raptis MD, FICS, FACS, Surgeon and Surgical Oncologist , Β’ Surgical Clinic , Aristotle Univer-sity of Thessaloniki, General Hospital of Thessaloniki G. Gennimatas, Thessaloniki, Greece

A. Sebio Garcia MD, Sarcoma Unit, Hospital Santa Creu i Sant Pau, Barcelona, Spain

V. Sioulas MD, PhD, Gynecologic Oncologist (MSKCC/ESGO), Head of the Department of Gyneco-logic Oncology, MITERA Hospital, Athens, Greece

E. Skarpidi MD, FCAP, Pathologist, Hygeia Hospital, Athens, Greece

S. Stacchioti MD, OM2 - Cancer Medicine Department, Adult Sarcoma Medical Treatment Unit, National Tumor Institute Milan, Italy

N. A. Stavropoulos MD, PhD, Orthopaedic Surgeon, Academic Fellow, 2nd Department of Ortho-paedic Surgery, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece

A. Stergioula MD, Radiation Oncologist, Department of Radiation Oncology, IASO Hospital, Ath-ens, Greece

E.S. Tripodaki MD, PhD, Fellow in Medical Oncology, Saint Savvas Anticancer Hospital, Athens, Greece

I. Tzaninis MD, Medical Director, Department of Oncology, Athens Medical Center, Athens, Greece

M. Wartenberg Patient Support & Advocacy Expert, President of SPAEN - Sarcoma Patients Eu-roNet Assoc., Board Member of the new German Sarcoma Foundation, Germany

H. Vasilatou - Kosmidis MD, Pediatric Hematologist - Oncologist, Director of Pediatric and Ado-lescent Oncology Clinic, Children’s Hospital MITERA, Athens, Greece

L. Vini MD, FRCR, Radiation Oncologist, Director of Radiotherapy Department, Athens Medical Center, Athens, Greece

M. Vlychou Professor of Radiology, School of Medicine, University of Thessaly, Thessaly, Larissa, Greece

FACULTYG. Agrogiannis Histopathologist, Associate Professor, 1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

I. Athanasiadis Medical Oncologist, Director of Oncology Clinic, Ass. Professor of Oncology, Northwestern University, Chicago, U.S.A.

D. Bafaloukos MD, PhD, Medical Oncologist, Emeritus Professor of University of W.A., Director of 1st Oncology Department Metropolitan Hospital, Athens, Greece

S. Bonvalot Department of surgery, Sarcoma unit, Institut Curie, Paris, France

I. Boukovinas MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, Bioclinic Thes-saloniki, Greece

A. Constantinidou MD, MRCP, MSc, PhD, Medical Oncologist, Medical School University of Cyprus & BoC Oncology Centre, Nicosia, Cyprus

M. Cordeiro Medical Oncologist, Center Hospital University of Algarve, Faro, Portugal

E. de Bree Associate Professor of General Surgery and Surgical Oncology Medical School of Crete, Department of Surgical Oncology University Hospital of Heraklion, Greece

K. Diamantopoulou MD, Head of Pathology Department, KAT Hospital, Athens, Greece

A. Digκlia MD, MSc, Consultant Oncologist, Department of Oncology, University Hospital of Lau-sanne (CHUV), Lausanne, Switzerland

J. Durán Moreno MD, Medical Oncologist, Member of the Spanish Sarcoma Group, General On-cologic Hospital of Kifissia “Agioi Anargyroi”, Athens, Greece

V. Georgoulias Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Greece

D. Diakoumis MD, Orthopedic Consultant, Orthopedic Department, Saint Savvas Anticancer Hos-pital, Athens, Greece

A. Karatzas MD, PhD, Olympion Therapeutirio, Telemedicineclinic, Patras, Greece

D. Kelekis Professor of Radiology, Director of Imaging and Interventional Radiology, IASO Hos-pital, Athens, Greece

S. Kokkali MD, MSc, Consultant Medical Oncologist, 1st Department of Medical Oncology, Saint Savvas Anticancer Hospital, Athens, Greece

V. Kontogeorgakos Assistant Professor of Orthopaedics Surgery, Medical School, University of Athens, Athens, Greece

I. Kotsantis MD, MSc, PhD (ca), 2nd Propaedeutic Internal Medicine Clinic & Research Unit - Oncol-ogy Unit Attikon University General Hospital, Athens, Greece

I. Karavokyros Associate Professor of Surgery, 1st Department of Surgery, Medical School, Na-tional and Kapodistrian University of Athens, Athens, Greece

D. Kypraios MD, Gastroenterologist, Saint Savvas Anticancer Hospital, Athens, Greece

A. Kyriazoglou MD,PhD, Oncology unit, Department of clinical therapeutics, Alexandra General hospital, Athens, Greece

E. Lianidou PhD, Professor of Analytical Chemistry - Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece10

1312

INFOOrganizer

Hellenic Oncology Research Group

with the Scientific Collaboration of

Hellenic Group of Sarcoma and Rare Cancer

Under the Auspices of Hellenic Society of Medical Oncology

DateMarch 15-16, 2019

Venue Royal Olympic Hotel 28-34 Athanasiou Diakou Str.117 43, Athens, GREECETel.: +30 210 92.88.400Fax.: +30 210 92.33.317E-mail: info@royalolympic.com

Official languageThe official language of the Masterclass is English

Certificate of AttendanceThe certificate of attendance will be given to the participants at the end of the event. Based on the latest circular of the National Drug Organization the Event is required to use an attendance tracking system. By the end of the event a certificate will be given to those who have attended at least 60% of the total hours of the scientific Program.

The Secretariat

Congress & Event Planning2-4, Kastriotou Str., P.O. 11476, Athens - Greece Τ +30 210 7294559 E info@eventema.gr

SPONSORS

14

NOTES

Congress & Event Planning2-4, Kastriotou Str.,

P.O. 11476, Athens - Greece Τ +30 210 7294559 E info@eventema.gr